Phenomenex has introduced Strata-X-Drug N, its second solid-phase extraction (SPE) sorbent designed for the extraction of drugs of abuse in forensic toxicology.
The new sorbent targets neutral drugs such as barbiturates and benzodiazepines.
Like its counterpart for basic drugs-of-abuse testing, Strata-X-Drug B, the new sorbent saves time and reduces solvent expense because it does not require conditioning or equilibration.
The company said that it conducts stringent QC tests on Strata-X-Drug N products; each batch is tested by extracting lorazepam and temazepam from actual urine samples, which delivers more realistic results than testing from spiked water.
Samples prepared using Strata-X-Drug N are ready for LC or GC analysis, and methods are available using Phenomenex Kinetex (LC) and Zebron (GC) columns.
'Our QC processes use biological samples to ensure the sorbent will perform as expected in customer analyses,' said Erica Pike, brand manager for Phenomenex.
Strata-X-Drug N is offered in 1ml, 3ml, 6ml and 12ml SPE tubes and in 96-well plates.
